Similar heart failure hospitalization and survival benefits are associated with Sacubitril/Valsartan therapy in CRT non responders and in HFrEF patients with no CRT indication

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Clinical heart failure from diagnostics to treatment Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by